Patron In Chief, Student Research Forum
I am proud to see the Student Research Forum nurturing a strong culture of scientific curiosity and academic excellence at Dow Medical College. May it continue to inspire, innovate, and lead the way for future researchers.
Chairperson, Student Research Forum (SRF)
It is an honor to lead SRF-DMC , a platform dedicated to foster research. Through mentorship, workshops, and global engagement, we empower students to think critically and contribute to meaningful scientific progress. I encourage all students to seize this opportunity, explore research, and shape the future of healthcare.
Panelist
Professor & Section Head, Department OF CHS. Aga Khan University
Panelist
Professor and Associate Dean, Research and Innovation Aga Khan University
Panelist
Head of the Department - Biochemistry, Dow Medical College
Panelist
Head of the Department - Pathology, Dow Medical College
Panelist
Head of Radiation Oncology, Aga Khan University
Panelist
Professor Section of Radiation Oncology, Aga Khan University
Panelist
Senior Instructor (Research) Public Health Gold Medalist Opthalmology And Visual science department, Agha Khan Hospital
Panelist
Assistant Professor, Department of Community Health Sciences, Agha Khan University.
Panelist
Fellow of Higher Education Academy, Higher education Acedemy, UK, 2018 European Society of Human Reproduction & Endocrinology Endocrine Society Pakistan Biological Safety Association Pakistan Physiological Society Pakistan Medical Association Board of Studies Ziauiddin University
Panelist
Faculty Research Advisor at the International FAIMER Institute, ECFMG-USA Life WONCA-affiliated College of Family Medicine Pakistan, PPS, DoHAD, and PBSA Reviewer - PlosOne, JPMA, BMJ STEL, BMC, and Frontiers
Panelist
Chairperson, Department of Surgery Principal, School of post graduate studies Director, Directorate of Global Engagement Head of Department of Upper G.I, Bariatric & General Surgery Unit-I,Civil Hospital,Karachi
Panelist
Assistant Professor and Research supervisor Dow Medical College
Panelist
Assistant Professor / Research supervisor Dow Medical College
Keynote Speaker
Dr Enam is the Director of the AKU's Centre for Regenerative Medicine and Stem Cell Research. He is a US Board-certified neurosurgeon and professor of neurosurgery. He previously served as the chair of the Department of Surgery at the Aga Khan University, Karachi. With a PhD in Neuroscience from Northwestern University and over 300 manuscripts, he is actively involved in clinical and basic science research in cellular and molecular neuroscience and neuro-oncology. Dr Enam is also the Founding President of the Pakistan Society of Basic and Applied Neuroscience, Pakistan Society of Neuro-Oncology and a member of the executive committee of the leading brain tumour consortium of the American Association of Neurological Surgeons and Congress of Neurological Surgeons. Based on his contributions to medicine and research, he has been awarded several accolades including Sitara-e-Imtiaz, the third-highest civilian award by the Government of Pakistan.
Keynote Speaker
Saleem Islam, M.D., M.P.H. is a Professor of Surgery and Pediatrics at the University of Florida College of Medicine. He served as Chief of Pediatric Surgery (2015–2022) and was Program Director of the Pediatric Surgery Fellowship (2009–2019). A graduate of Aga Khan University, Dr. Islam completed his surgical training at the University of Massachusetts, with further fellowship training at Harvard/Mass General and the University of Michigan. He joined UF in 2007 and has held key clinical and academic leadership roles. Dr. Islam is a Fellow of the American College of Surgeons and the American Academy of Pediatrics, and a member of leading surgical societies including the American Surgical Association. He has authored over 160 peer-reviewed publications and delivered 200+ national and international presentations. His research interests include pediatric gastroparesis, health equity, and outcomes-based pediatric surgical care.
Keynote Speaker
Dr Karim Damji is Professor and Chair of the Department of Ophthalmology and Visual Sciences (OVS) at the Aga Khan University in Karachi, Pakistan. He was Chair of OVS at the University of Alberta from 2014-21. He was former fellowships director at OVS, Univ. of Alberta and residency program director at Univ.
Keynote Speaker
Dr. Zakiuddin Ahmed is a visionary strategist, entrepreneur and a physician leader who specializes in developing sustainable, scalable and innovative solutions in Healthcare through information & communications technology. He’s the pioneer of Telemedicine and eHealth in Pakistan and has many “Pakistan’s firsts” to his credit in the digital health space. He has mentored many digital health startups, is on the board of international companies, and delivers regular key note invited lectures at global conferences.
We are pleased to invite students and early-career researchers to submit abstracts for presentation at the National Health Research Conference 2025. This event aims to provide a national platform for showcasing innovative research in medicine and allied health sciences, fostering collaboration, and promoting evidence-based clinical practice and public health initiatives. Please read the following instructions carefully before submitting your abstract:
1. Eligibility
Abstract submissions are open to undergraduate, postgraduate students and healthcare professionals from all disciplines of health and biomedical sciences. Abstracts must represent original research or novel case studies. Studies must be complete at the time of submission. Research proposals or projects that are still in progress will not be considered for presentation. Unpublished research is preferred to research projects that have already been published in a journal. Abstracts that are being considered for, will be presented at, or have already been presented at another conference are eligible for submission.
2. Conference Themes & Categories
We welcome submissions in the following broad domains: Medicine Surgery Oncology Public Health Pharmacology and Drug Development Other
Note: These categories are used solely to organize submissions for review. They are not strict divisions and will not influence the acceptance of your abstract.
3. Types of Accepted Study Designs
We accept a range of study types which include:
Systematic Reviews & Meta-Analyses:
Must specify inclusion/exclusion criteria, search strategy, and pooled data analysis.
Case Reports:
Should present rare or novel cases with clear clinical relevance. Patient consent and ethical approval must be documented.
Case-Control Studies:
Describe criteria for group selection, matching methodology, and analysis.
Observational Studies (Cross-sectional, Cohort):
Include details of population sampling, variables measured, and study duration.
Pre/Post Studies Without Control Group:
Must clearly show baseline and post-intervention comparisons, preferably with statistical support.
4. Author and Presenter guidelines
Authorship should be limited to individuals who have made a direct and substantial contribution to the writing of the abstract, preparation of the presentation, or will be actively involved in its delivery. However, to be eligible for presentation, the presenting author must be a current medical student or enrolled in an allied health sciences undergraduate program. It is not necessary for the presenting author to be listed first among the co-authors. A student may be listed as the presenting author on multiple abstracts, but if more than one is accepted, they will be allowed to present only one. In such cases, another eligible co-author must present the additional accepted abstracts.
5. Abstract Structure Guidelines
Each abstract must be structured into the following subsections:
Title: Clear and concise, reflecting the core of the research.
Authors & Affiliations: Full names of all authors with institutional affiliations and email of the corresponding author.
Introduction/Background: Brief context and rationale; state the knowledge gap.
Objective(s): Clearly define the primary aim(s) of the study.
Methods: Study design, sample size, setting, duration, statistical tools, and ethical approval (if applicable).
Results: Summarize key findings. Use numerical data with appropriate statistical interpretation.
Conclusion: Interpret your results and state their potential implications.
Keywords: 3–5 keywords relevant to your study.
Disclosure/Conflict of Interest: Must be declared if applicable.
Supplementary Material: Authors may choose to include one original figure or table to support the results presented in their abstract. This is optional and will not influence the evaluation or acceptance of the submission. Abstracts without a figure or table are assessed equally to those that include one. Only original figures or tables are permitted. Any figure or table must be free of patient identifiers or any information that could compromise confidentiality, such as names, medical record numbers, or unmasked clinical images.
6. Abstract Format & Submission Structure:
Abstracts should be structured as follows:
Background | Objectives | Methods | Results | Conclusion
Word Limit: Maximum 300 words (excluding title, author info, and keywords).
Font: Times New Roman, 12 pt
Spacing: 1.5 line spacing
Margins: 1-inch on all sides
File Format: Microsoft Word (.doc or .docx)
File Naming Format:
Abstract_FirstAuthorLastName_ShortTitle.docx
Example: Abstract_Ali_DiabetesTrends.docx
Language: English only.
7. Review Process
All abstracts will be peer-reviewed by a Scientific Review Committee based on: Scientific merit Originality and novelty Clarity and organization Relevance to the stated categories Ethical considerations
Note: All abstracts will be screened for originality. Submissions with plagiarized content will be disqualified.
Please ensure all items are completed prior to submission.
Author & Abstract Information
The title is specific, clear, and no longer than 20 words. It reflects the content and type of study (e.g., “A Cross-Sectional Study of…”). Full names of all authors listed in proper order (First Name, Last Name). Author affiliations are complete, including institution, department, city, and country. The corresponding author is clearly identified, with an active email and phone number.
Abstract Formatting & Structure
The abstract adheres to the word limit of 300 words (excluding title, author information, and keywords). A structured format is used, including the following headers: Background Objectives Methods Results Conclusion If submitting a case report, it should include: Introduction Case Presentation Discussion Conclusion The abstract is written in English, using Times New Roman, 12-point font, with 1.5 line spacing and 1-inch margins on all sides. Submission is in Microsoft Word format (.doc or .docx). File is named according to the required format:
Abstract_FirstAuthorLastName_ShortTitle.docx
e.g., Abstract_Ali_DiabetesTrends.docx Figure or table may be included (only one is allowed), however it is optional. Abbreviations to be minimized and spelled out at first mention. SI units are used throughout.
Content & Language Quality
The title is phrased, not a full sentence, and clearly conveys the focus of the study. The background provides context and explains the study’s rationale. The objective clearly outlines what the research aimed to accomplish. The methods section clearly describes study design, setting, participant criteria, interventions (if any), analysis tools, and limitations. The results are well-defined and include descriptive and inferential data (use SD for means, IQR for medians, and exact p-values unless <0.0001). The conclusion summarizes findings and discusses their implications. The abstract demonstrates originality and avoids widely covered or redundant topics. The writing is clear, grammatically correct, and free of spelling errors. There are no citations and references. Plagiarism is strictly prohibited and will lead to disqualification.
Ethical & Scientific Compliance
Ethics approval has been obtained for studies involving human or animal subjects (if applicable). Informed consent is documented for case reports or studies involving human subjects. Conflicts of interest for all authors are declared.
If none, include the statement: “We declare no conflicts of interest.” Funding sources are disclosed (if applicable).
If none, state: “No funding was received.”
Research Type & Presentation Preference
Please specify your preferred mode of presentation:
☐ Oral
☐ Digital Poster
☐ Either Virtual
Please ensure you abstract is categorized under one of the following:
☐ Medicine
☐ Surgery
☐ Oncology
☐ Public Health
☐ Pharmacology / Drug Development
☐ Other (please specify): ___________
Final Confirmation Before Submission
Please make sure that you read through and strictly adhere to our official Abstract Submission Guidelines. This is the final version; no revisions or withdrawals will be permitted post-submission. The submission must be proofread for coherence, clarity, and flow.
All submissions are final. Please ensure accuracy and compliance with every listed item before submitting.
The National Health Research Conference 2024 was dedicated to promoting student-led research across health-related fields. It provided a platform for students to present their work, engage with experts, and participate in insightful panel discussions. With both virtual and in-person formats, the conference attracted a diverse global audience and featured a multidisciplinary showcase of the latest advancements in health research.